COGT Reports Fourth Quarter and Full Year 2025 Financials, Submits SUMMIT NDA, Initiates PEAK NDA, Tracks APEX NDA Submission, Strong Balance Sheet with $901M Cash Position
Cogent Biosciences, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $34.96
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS